Project Overview

A leading global biopharma company commissioned us to quantify how healthcare professionals (HCPs) interact with pharmaceutical and biotech manufacturers in four dynamic Asia-Pacific markets—Singapore, Philippines, Malaysia and Taiwan. More than 600 physicians spanning primary care, paediatrics, internal medicine subspecialties, dermatology, oncology and critical-care anaesthesia completed an online survey. The study explores practice patterns, information channels and perceptions that ultimately guide treatment decisions and collaboration with industry partners.

Key Learning Objectives

• Practice Dynamics – Measure how HCPs allocate clinical time, manage patient volumes and incorporate vaccination counselling.

• Engagement Footprint – Profile the frequency, format and perceived value of interactions with pharma/biotech representatives.

• Information Flow – Identify the most trusted content types—scientific data, product updates, patient-support resources—and the actions they trigger.

• Service Gaps & Preferences – Reveal unmet needs and satisfaction drivers to inform more effective, mutually beneficial engagement models.

Methodology

• Online Quantitative Survey

  • ~150 respondents per country; stratified sampling across key specialties.

  • Questionnaire modules covering clinical workload, interaction channels (in-person, virtual, digital), content relevance, and partnership outcomes.

• Advanced Analytics

  • Segmentation to pinpoint attitudinal clusters.

  • Multivariate modelling to rank factors that influence HCP satisfaction and behavioural follow-through.

Key Deliverables

• Country Dashboards highlighting engagement patterns, channel preferences and content priorities.

• Opportunity Matrix mapping service gaps against HCP segment potential for tailored outreach strategies.

• Strategic Recommendations to optimise field-force deployment, digital touchpoints and medical-education offerings—positioning the client for stronger, compliant partnerships in the coming years.